期刊文献+

宫颈细胞学阴性患者高危型HPV含量与CIN2及更高级别病变的相关性 被引量:7

Relationship Between High-risk Human Papillomavirus and CIN2 or High Grade in Patients with Negative Cervical Cytology
原文传递
导出
摘要 [目的]探讨高危型人乳头状瘤病毒(HPV)检测对宫颈液基细胞学阴性妇女宫颈上皮内瘤变(CIN)的诊断价值。[方法]收集宫颈癌筛查中细胞学阴性而高危型HPV阳性的妇女498例,行阴道镜下宫颈活检。分析高危型HPV负荷量与CIN2^+的相关性。[结果]在498例患者中,CIN2^+病变者共65例,占13.1%。高危型HPV〈10的257例中患CIN2^+有13例,占5.1%。高危型HPV10-100和〉100的病例中患CIN2^+比例分别为18.2%(26/143)和26.5%(26/98)。各组之间的CIN2^+比例差异有统计学意义(χ^2=93.673,P=0.000)。在调整年龄因素后,高危型HPV 10-100患CIN2^+的风险是〈10者的2.356倍(95%CI:1.449-8.828),而〉100者患CIN2^+的风险是〈10者的3.595倍(95%CI:2.214-13.533)。[结论]高危型HPV负荷量与CIN病变级别密切相关,高危型HPV负荷量越高,患CIN2+的危险度越高。 [Purpose] To investigate the value of high-risk human papillomavirus(HR-HPV) in the diagnosis for cervical intraepithelial neoplasia(CIN) with negative liquid-based cytology. [ Methods ] A total of 498 women with positive HR-HPV and negative cytology were enrolled. All cases underwent colposcopic guided biopsy.The relationship of the load of HR-HPV and CIN2 or worse was analyzed. [Results] Of 498 patients,65 patients were CIN2^+ lesions, accounting for 13.1%. The ratio of CIN2+ was 5.1% in HR-HPV〈10 group,while it was 18.2%(26/143)in HR-HPV10~ 100 group and 6.5% (26/98)in HR-HPV〉100 group,with significant difference among the 3 groups (χ^2=93.673 ,P=0.000). After adjustment of the age,the risk of CIN2^+ in patients with HRHPV 10 - 100 was higher that that in patients with HR-HPV 〈10 (OR =2.356,95% CI : 1.449 - 8.828) ,while the risk of CIN2^+ in patients with HR-HPV 〉100 was higher than that in patients with HR-HPV〈 10(OR=3.595,95%CI : 2.214-13.533). [ Conclusions ] The load of HR-HPV closely relates to grade of CIN. The higher the load of HR-HPV ,the higher the risk of of CIN2^+.
出处 《肿瘤学杂志》 CAS 2015年第3期233-236,共4页 Journal of Chinese Oncology
关键词 宫颈上皮内瘤变 人乳头状瘤病毒 液基细胞学 cervical intraepithelial neoplasia human papillomavirus liquid-based cytology
  • 相关文献

参考文献2

二级参考文献20

  • 1乌兰娜,张礼婕,刘志红,周艳秋,黄秀浓,吴瑞芳.人乳头瘤病毒检测在宫颈癌筛查中的作用[J].齐齐哈尔医学院学报,2005,26(6):611-613. 被引量:12
  • 2耿晓星,马荣,朱镭,高庆玉.HPV和TCT检测对LEEP治疗CIN效果的监测意义[J].中国肿瘤临床,2006,33(11):608-610. 被引量:5
  • 3戴志琴,潘凌亚,黄惠芳,郎景和.子宫颈上皮内瘤变Ⅲ级患者的术后随诊及其影响因素[J].中华妇产科杂志,2007,42(2):107-110. 被引量:23
  • 4Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999, 189:12 - 19.
  • 5Sehlecht NF, Kulaga S, Robiaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA, 2001, 286: 3106-3114.
  • 6Sankaranarayanan R, Nene BM, Shastri .KS, et al. HPV screening for cervical cancer in rural India. N Engl J Med, 2009, 360: 1385-1394.
  • 7Kjaer S, Hogdall E, Frederiksen K, et al. The absolute risk of cervical abnormalities in high- risk human papillomavirus - positive, cytologically normal women over a 10 year period. Cancer Res, 2006, 66: 10630- 10636.
  • 8Dillner J, Rebolj M, Birembaut P, et al. Long term predic tive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ, 2008, 337: a1754.
  • 9Wright TC Jr, Schiffman M, Solomon D, et al. Interim guid- ance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology [or screening. Obstet Gynecol, 2004, 103: 304-309.
  • 10Pretet JL, Dalstein V, Monnier Benoit S, et al. High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real time PCR in cervical smears of HPV16 infected women. J Clin Virol, 2004, 31: 140- 147.

共引文献34

同被引文献74

  • 1邓云.LEEP术治疗宫颈癌前病变的有效性[J].世界临床医学,2017,11(1):118-118. 被引量:3
  • 2郝永楠,赵伟佳.Nestin的研究进展[J].广西医科大学学报,2007,24(4):650-652. 被引量:5
  • 3Haguenoer K, Giraudeau B,Gaudy-Graffin C,et al.Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: A cross-sectional study[J]. Gynecologic Oncol,2014,134(2):302-308.
  • 4Perry KU,Luyten A,Scherbring S.Accuracy of colposcopy mana- gement to detect CIN3 and invasive cancer in women with abnormal screening tests: Results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, Germany[J].Gynecol Oncol,2013,128(2) :282-287.
  • 5Akiyama M, Matsuda Y, Ishiwata T, et al. Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma [ J ]. J Invest Dermato1,2013,133 (5) : 1384-1387.
  • 6Milde T, Hielseher T, Witt H, et al. Nestin expression identifies ependymoma patients with poor outcome [ J ]. Brain Pathol,2012, 22(6) :848-860.
  • 7Nielsen A, Kjaer SK, Munk C, et al. Persistence of high-risk hu- man papillomavirus infection in a population-based cohort of Dan- ish women [J]. J Med Virol,2010,82(4) :616-623.
  • 8SundstrSm K, Ploner A, Dahlstm LA, et al. Prospective study of HPV16 viral load and risk of in situ and invasive squamous cer- vical cancer [ J ]. Cancer Epidemiol Biomarkers Prey, 2013,22 (1) :150-158.
  • 9Park D, Xiang AP, Mao FF, et al. Nestin is required for the proper self-renewal of neural stem cells I J]. Stem Cells,2010, 28 (12) :2162-2171.
  • 10Bortolomai I, Canevari S, Faeetti I, et al. Tumor initiating cells : development and critical characterization of a model derived from the A431 carcinoma cell llne forming spheres in suspension [ J ]. Cell Cycle,2010,9 ( 6 ) : 1194-1206.

引证文献7

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部